NCT00068003 2026-04-14Harvesting Cells for Experimental Cancer TreatmentsNational Institutes of Health Clinical Center (CC)Enrolling by invitation7,000 enrolled
NCT07218003 2026-03-23A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4Rondo TherapeuticsPhase 1 Enrolling by invitation149 enrolled
NCT05645536 2026-01-12Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA StudyTolmar Inc.Phase 3 Enrolling by invitation250 enrolled